Followers | 79 |
Posts | 24,556 |
Boards Moderated | 1 |
Alias Born | 09/08/2000 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LUNR - 4.99 Pre-market at 5.85/5.99
Intuitive Machines Shares Jump 27% on Stake Reported by Co-Founder Kamal Ghaffarian
WISH - 4.50 Pre-market at 6.19/6.24
ContextLogic Announces Agreement To Sell Substantially All Operating Assets And Liabilities Associated With Wish To Qoo10 For $173M In Cash Or ~$6.50/Share
MGIH - 1.03 Pre-market at 2.18/2.19
Millennium Group International Shares Up 139% Premarket; YC 1926 (BVI) Limited Reported A 88.89% Stake In A 13G Filing On Friday
BMR - 2.11 Pre-market at 3.62/3.64
Beamr and NVIDIA team up to accelerate adoption of the newest video standard - AV1
SPCB - .1836 Pre-market at .26/.2618
SuperCom Announces New EM Contract In California, Terms Not Disclosed
UAVS - .0785
AgEagle shares are trading higher after the company announced a contract for eBee X and eBee TAC drones for use by the US Department of Energy Laboratory.
BIOL - .4259 Up .06
Biolase Expects Full-Year 2024 Revenue Of $52M-$53M, Up 6%-8% Y/Y Compared To The Consensus Of $53.01M; The Company Expects To Improves Loss From Operations By 50%-60%
HOLO - 37.38 Up 19.38
MLGO - .57 Pre-market at .93/.94
IKT - 2.98 Pre-market at 3.23/3.29
Inhibikase Reports Preliminary Outcomes Of Pre-NDA Meeting With FDA On Pathway For Approval For IkT-001Pro In Blood And Gastrointestinal Cancers; Says Given Specific Guidance On Manufacturing Requirements Necessary To Complete NDA
HOLO - 1.51 Pre-market at 2.29/2.30
MicroCloud Hologram Planned to Join the Communications Industry Association
LLY - 706.20 Pre-market at 741.55/741.98
Eli Lilly Experiencing Delays Fulfilling Orders of Trulicity, Mounjaro -- Market Talk
754 ET - Eli Lilly is dealing with delays in fulfilling orders of some of its top diabetes medications. The drugmaker says it has experienced and continues to experience intermittent delays fulfilling orders of Trulicity, a type 2 diabetes medication, which have impacted and will continue to weigh on volumes. Trulicity revenue in the U.S. was down 18% in 4Q due in part to this volume headwind, along with lower prices. The company is also experiencing intermittent delays fulfilling orders of certain doses of Mounjaro, which is used to treat type 2 diabetes and also obesity, due to significant demand. (dean.seal@wsj.com)
(END) Dow Jones Newswires
HSDT - 7.05 Pre-market at 10.23/10.25
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
XCUR - .5597 Pre-market at .73/.7389
Exicure shares are trading higher after the company announced it entered into a patent license agreement with Bluejay Therapeutics to develop cavrotolimod for the potential treatment for hepatitis.
AGFY - .6401 Pre-market at .98/.9801
Agrify Corporation Achieves Milestone with PX-30 Hydrocarbon Extraction System Installation in Michigan Facility
NVIV - .222 Pre-market at .315/.316 ....I don't understand why this is up.
InVivo Therapeutics Holdings And Subsidiary Filed For Chapter 11 Bankruptcy In Delaware But Plan To Continue Operating Under Court Supervision As A Debtor-In-Possession.
PLUG - 4.70 Pre-market at 4.82/4.83
Plug Signs BEDP Contract for a 500MW Electrolyzer in Europe
CISS - .1367 Pre-market at .159/.1597
SIDU - 4.83/4.93 News out at 8:31 AM EST
National Geospatial-Intelligence Agency Awards IDIQ Research and Development Contract with $794 Million Ceiling to Solis Applied Science Team, Including Sidus Space
BLBX - 3.24 Pre-market at 3.40/3.43
Blackboxstocks, Inc. Acquisition Target Evtec Aluminium Receives New $67 Million Long Term Supply Contract from Jaguar Land Rover
MINM - 4.10 Pre-market at 4.55/4.60
Minim Rises After Investor David Lazar Buys 2M Preferred Shares
AUVI - 2.65 Pre-market at 2.94/2.95
Applied UV, Inc. to Develop Smart Building Technologies for Larimar City, a New Luxury Development With Six Hotels and 20,000 High-end Residences - Potential Revenues Could Total $250 Million to $300 Million
PLUG - 4.45 Pre-market at 5.07/5.08
Plug Power Says It Completed First Customer Fill of Liquid Green Hydrogen at its Georgia Plant
KPRX - .5524 Pre-market at .7582/.759
Kiora Pharmaceuticals Grants License to Thea Open for Molecular Photoswitch Product - Shares Surge
ADAP - .96 Pre-market at 1.08/1.09
Adaptimmune Therapeutics Says US FDA Grants Priority Review for Potential Sarcoma Therapy Application -- Shares Rise
PLUG - 3.73 Pre-market at 4.07/4.08
GHSI - 5.15 Pre-market at 9.65/9.75
Guardion Health Sciences Announced Entry Into Definitive Agreement to Sell Its Viactiv Brand And Business to Doctor's Best For $17.2M Cash
ENSC - 1.44 Pre-market at 2.05/2.07
Ensysce Biosciences Reports Completion Of A Constructive End Of Phase 2 Meeting With FDA Regarding Its Lead 'Next Generation' Analgesic, PF614; Phase 3 Program Expected To Begin Enrollment In Mid-2024
MINM - 2.54 Pre-market at 3.01/3.04
Minim Rises After Investor David Lazar Buys 2M Preferred Shares
TRIB - .4349 Pre-market at .5601/.5669
Trinity Biotech Announces Acquisition Of The CGM Assets Of Waveform Technologies, Inc.; Upfront Payment Of $12.5M Cash And 9M ADSs
SINT - .3921/.3943 Up .1543
SINTX Technologies Subsidiary Technology Assessment & Transfer Enters Into Cooperative Research And Development Agreement With U.S. Army; Financial Terms Not Disclosed
PHIO - .72/.7362 Up .1532 with this news.
Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
SPRC - 3.89 Pre-market at 4.11/4.19
SciSparc Has Initiated Patient Recruitment For Its Clinical Trial In Children Suffering From Autism Spectrum Disorder At Soroka Medical Center In Israel
TPST - 3.895 Pre-market at 4.04/4.07
Tempest Therapeutics Announces Advances In Liver Cancer Treatment, Showcasing Exceptional Efficacy And Safety Data At ASCO Annual Meeting 2024
PTPI - 1.385 Pre-market at 1.70/1.72
AGFY - .505824 Pre-market at .897/.9014
C3is 13G Filing Shows S.H.N. Financial Reported A 9.1% Stake In The Co
CISS - .1351 Pre-market at .18/.1801
C3is 13G Filing Shows S.H.N. Financial Reported A 9.1% Stake In The Co
REVB - 9.866 Pre-market at 18.65/18.81
RNAZ - .7599 Pre-market at .86/.8663
TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
PRZO - .77 Pre-market at .829/.8303
ParaZero Technologies Has Completed A Significant Drone Safety Project With An Undisclosed Fortune 500 Automotive Manufacturer For Their Proprietary Drone Program